Development of an anti-human EphA2 monoclonal antibody Ea2Mab-7 for multiple applications
Ephrin type A receptor 2 (EphA2) binds to membrane-bound ligands, ephrin A1, A2, and A5, eliciting bidirectional signaling. This signaling regulates many physiological processes, such as tissue development, homeostasis, and regeneration. The dysregulation of the EphA2-ephrins axis contributes to var...
Saved in:
| Main Authors: | Hiroyuki Satofuka, Hiroyuki Suzuki, Tomohiro Tanaka, Guanjie Li, Mika K. Kaneko, Yukinari Kato |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-06-01
|
| Series: | Biochemistry and Biophysics Reports |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2405580825000858 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A novel anti-mouse CXCR1 monoclonal antibody, Cx1Mab-8, demonstrates nanomolar affinity in flow cytometry
by: Guanjie Li, et al.
Published: (2025-06-01) -
Plasma EphA2 level is a superior biomarker to Del-1 for sepsis diagnosis and prognosis
by: Eun Hye Lee, et al.
Published: (2025-01-01) -
EphrinA2 promotes glioma cell migration and invasion through EphA2 and FAK
by: Nozomi Hirai, et al.
Published: (2025-05-01) -
Development of a novel anti-human glypican 5 monoclonal antibody (G5Mab-1) for multiple applications
by: Yu Kaneko, et al.
Published: (2025-09-01) -
Adaptive RSK‐EphA2‐GPRC5A signaling switch triggers chemotherapy resistance in ovarian cancer
by: Lidia Moyano‐Galceran, et al.
Published: (2020-03-01)